Risk of Malignancy and Tuberculosis of Biological and Targeted Drug in Patients With Spondyloarthritis: Systematic Review and Meta-analysis of Randomized Controlled Trials

Objective: Concerns exist regarding the potential development of malignancy and tuberculosis in patients with spondyloarthritis (SpA) treated with biologics. We assessed the extent to which biologic therapy may increase the risk of malignancy and tuberculosis in patients with SpA by meta-analysis to...

Descripción completa

Detalles Bibliográficos
Autores principales: Man, Siliang, Hu, Lidong, Ji, Xiaojian, Wang, Yiwen, Ma, Yingpei, Wang, Lei, Zhu, Jian, Huang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585981/
https://www.ncbi.nlm.nih.gov/pubmed/34776944
http://dx.doi.org/10.3389/fphar.2021.705669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585981/
https://www.ncbi.nlm.nih.gov/pubmed/34776944
http://dx.doi.org/10.3389/fphar.2021.705669

Ejemplares similares